Charles Muller, MD Chair, CGA-IGC Communications Committee Does PDL-1 blockade therapy allow for non-operative management of MMR deficient locally advanced rectal cancer? “I’m obviously a big advocate of this approach, but I realize that it’s challenging because it is not yet standard of care” – Andrea Cercek, MD, Memorial Sloan Kettering Cancer Center. This episode, hosted by Matt Yurgelun, MD from Dana Farber Cancer Center in Boston, MA features Zsofia Stadler, MD & Andrea